Kandarakis SA - Search Results

1

Emerging role of advanced glycation-end products (AGEs) in the pathobiology of eye diseases.

Kandarakis SA, Piperi C, Topouzis F, Papavassiliou AG. Kandarakis SA, et al. Prog Retin Eye Res. 2014 Sep;42:85-102. doi: 10.1016/j.preteyeres.2014.05.002. Epub 2014 Jun 4. Prog Retin Eye Res. 2014. PMID: 24905859 Review.

2

Dietary glycotoxins induce RAGE and VEGF up-regulation in the retina of normal rats.

Kandarakis SA, Piperi C, Moschonas DP, Korkolopoulou P, Papalois A, Papavassiliou AG. Kandarakis SA, et al. Exp Eye Res. 2015 Aug;137:1-10. doi: 10.1016/j.exer.2015.05.017. Epub 2015 May 28. Exp Eye Res. 2015. PMID: 26026876

3

Pathophysiology and types of dyslipidemia in PCOS.

Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA, Chrousos GP. Diamanti-Kandarakis E, et al. Among authors: kandarakis sa. Trends Endocrinol Metab. 2007 Sep;18(7):280-5. doi: 10.1016/j.tem.2007.07.004. Epub 2007 Aug 10. Trends Endocrinol Metab. 2007. PMID: 17692530 Review.

4

Ocular nonsteroidal inflammatory drugs: where do we stand today?

Kandarakis SA, Petrou P, Papakonstantinou E, Spiropoulos D, Rapanou A, Georgalas I. Kandarakis SA, et al. Cutan Ocul Toxicol. 2020 Sep;39(3):200-212. doi: 10.1080/15569527.2020.1760876. Epub 2020 May 13. Cutan Ocul Toxicol. 2020. PMID: 32338073

5

Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism?

Diamanti-Kandarakis E, Livadas S, Kandarakis SA, Margeli A, Papassotiriou I. Diamanti-Kandarakis E, et al. Among authors: kandarakis sa. Eur J Endocrinol. 2008 Apr;158(4):525-31. doi: 10.1530/EJE-07-0822. Eur J Endocrinol. 2008. PMID: 18362300

6

Low free plasma levels of retinol-binding protein 4 in insulin-resistant subjects with polycystic ovary syndrome.

Diamanti-Kandarakis E, Livadas S, Kandarakis SA, Papassotiriou I, Margeli A. Diamanti-Kandarakis E, et al. Among authors: kandarakis sa. J Endocrinol Invest. 2008 Nov;31(11):950-5. doi: 10.1007/BF03345631. J Endocrinol Invest. 2008. PMID: 19169049

7

The impact of endocrine disruptors on endocrine targets.

Diamanti-Kandarakis E, Palioura E, Kandarakis SA, Koutsilieris M. Diamanti-Kandarakis E, et al. Among authors: kandarakis sa. Horm Metab Res. 2010 Jul;42(8):543-52. doi: 10.1055/s-0030-1252034. Epub 2010 Apr 23. Horm Metab Res. 2010. PMID: 20419622 Review.

8

Erythropoietin abuse and erythropoietin gene doping: detection strategies in the genomic era.

Diamanti-Kandarakis E, Konstantinopoulos PA, Papailiou J, Kandarakis SA, Andreopoulos A, Sykiotis GP. Diamanti-Kandarakis E, et al. Among authors: kandarakis sa. Sports Med. 2005;35(10):831-40. doi: 10.2165/00007256-200535100-00001. Sports Med. 2005. PMID: 16180943 Review.

9

A case of bilateral self-induced keratoconus in a patient with tourette syndrome associated with compulsive eye rubbing: case report.

Kandarakis A, Karampelas M, Soumplis V, Panos C, Makris N, Kandarakis S, Karagiannis D. Kandarakis A, et al. BMC Ophthalmol. 2011 Sep 21;11:28. doi: 10.1186/1471-2415-11-28. BMC Ophthalmol. 2011. PMID: 21936935 Free PMC article.

10

Response of corneal hysteresis and central corneal thickness following clear corneal cataract surgery.

Kandarakis A, Soumplis V, Karampelas M, Koutroumanos I, Panos C, Kandarakis S, Karagiannis D. Kandarakis A, et al. Acta Ophthalmol. 2012 Sep;90(6):526-9. doi: 10.1111/j.1755-3768.2010.02078.x. Epub 2011 Jan 14. Acta Ophthalmol. 2012. PMID: 21232083

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results